Abiomed Third Quarter Fiscal 2012 Earnings and Conference Call Notification

Published on Thursday, 26 January 2012 12:16 Written by TradersHuddle Staff

DANVERS, Mass.-( Business Wire )-

Abiomed, Inc. (NASDAQ: ABMD) announced today that on Friday, February 3, the Company will release financial results for the third quarter of fiscal 2012. The Company will host a conference call to discuss the results on Friday, February 3, 2012, at 8:00 a.m. ET. Michael R. Minogue, Chairman, President and Chief Executive Officer and Robert L. Bowen, Vice President and Chief Financial Officer, will host the conference call.

To listen to the call live, please tune into the webcast via http://investor.abiomed.com or dial (877) 638-9567; the international number is (253) 237-1032. A replay of this conference call will be available beginning at 11 a.m. ET on February 3rd, 2012 through 11:59 p.m. ET on February 17th, 2012. The replay phone number is 855.859.2056; the international number is 404.537.3406. The replay access code is 41415117.

ABOUT ABIOMED

Based in Danvers, Massachusetts, Abiomed, Inc., is a leading provider of medical devices that provide circulatory support to acute heart failure patients across the continuum of care in heart recovery. Our products are designed to enable the heart to rest, heal and recover by improving blood flow and/or performing the pumping of the heart. For additional information please visit: www.abiomed.com.

FORWARD-LOOKING STATEMENTS

This Release contains forward-looking statements, including statements regarding development of Abiomed's existing and new products, the Company's progress toward commercial growth, and future opportunities and expected regulatory approvals. The Company's actual results may differ materially from those anticipated in these forward-looking statements based upon a number of factors, including uncertainties associated with development, testing and related regulatory approvals, anticipated future losses, complex manufacturing, high quality requirements, dependence on limited sources of supply, competition, technological change, government regulation, future capital needs and uncertainty of additional financing, and other risks and challenges detailed in the Company's filings with the Securities and Exchange Commission, including the Annual Report filed on Form 10-K and the most recently filed Quarterly Report on Form 10-Q. Readers are cautioned not to place undue reliance on any forward-looking statements, which speak only as of the date of this Release. The Company undertakes no obligation to publicly release the results of any revisions to these forward-looking statements that may be made to reflect events or circumstances that occur after the date of this Release or to reflect the occurrence of unanticipated events.

Abiomed, Inc.Aimee Maillett, 978-646-1553Corporate Communications This e-mail address is being protected from spambots. You need JavaScript enabled to view it.